Friday Board Review

Board Review by Dr. Christine Collins

A 60 year old male presents to the hospital in cardiac arrest. After recognition of ventricular fibrillation, you successfully achieve ROSC with early CPR and defibrillation. The patient remains comatose. What is recommended post-resuscitation for this patient?

A: Maintain temperature at 30 degrees Celsius for 24 hours

B: Obtain and electroencephalogram

C: Targeted glucose range 90-130

D: Maintain oxygen saturation at 100%

Answer: Obtain an electroencephalogram

After cardiac arrest, the American Heart Association recommends early coronary artery catheterization (if suspected cardiac etiology), maintenance of hypothermia (between 32 and 36 degrees for 24 hours), controlled reoxygenation >94%, and avoidance of hypotension. For comatose patients, it’s recommended to obtain EEG to assess for subclinical seizure. About 12-22% of patient’s after cardiac arrest that remain comatose have epileptiform activity, and this can lead to worsening neurologic outcomes if not detected.

References: 

Callaway CW, Donnino MW, Fink EL, et al. Part 8: post-cardiac arrest care: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015;132(18 Suppl 2):S465–82.

Krumholz A, Stern BJ, Weiss HD. Outcome from coma after cardiopulmonary resuscitation: relation to seizures and myoclonus. Neurology 1988; 38:401.

Wednesday Image Review

What’s the Diagnosis? By Dr. Erica Schramm

25 year-old female presents following a fall from her horse 5 days ago. She complains of severe pain in the radial aspect of her right wrist and has no other injuries.  Plain films at an outside ED immediately following the injury were negative, and repeat plain films are shown here. What’s the diagnosis?

Answer: Non-displaced Scaphoid Waist Fracture

  • The most common carpal bone fracture (60-70% of all carpal fractures). 10-30% of scaphoid fractures are not detected on the first set of plain films, but “scaphoid view” plain films (i.e., AP wrist with ulnar deviation) can improve the view of the scaphoid.
  • If a scaphoid fracture is clinically suspected, the patient should be placed in a thumb spica splint and follow up in 7-10 days for repeat plain films and reexamination
  • The most feared complication of a scaphoid fracture is avascular necrosis (AVN) of the proximal fracture segment. AVN is more likely in unstable scaphoid fractures, for example those that are proximal, oblique, displaced >1 mm, rotated, or comminuted. These require surgical consult and long arm thumb spica splint.
  • Stable fractures can be splinted with a short arm thumb spica splint and patients should be instructed to follow up with orthopedics in 7-10 days

References:

Escarza, Robert et al. “Chapter 266. Wrist Injuries.” Tintinalli’s Emergency Medicine a Comprehensive Study Guide, 7e.  Eds, Judith E. Tintinalli, et al.  New York, NY: McGraw-Hill, 2011.

DeAngelis, Michael A and David A Wald. “Wrist.” Simon’s Emergency Orthopedics, 7e.  Ed. Scott C Sherman.  New York, NY: McGraw-Hill, 2014

Jordanov, Martin I and Robert Warne Fitch. “Chapter 9 Upper Extremity.” The Atlas of Emergency Radiology. Eds. Jake Block et al.  New York, NY: McGraw-Hill, 2013

Tuesday Advanced Cases

Critical Cases – TTP!

Thrombotic Thrombocytopenic Purpura

Pathology – microangiopathic (small vessel) hemolytic anemia 2/2 deficiency of ADAMTS13 (cleaves ultra large vWF into smaller subunits) 

High associated w/ HIV AIDS

4% have classic pentad (fever, anemia, thrombocytopenia, renal dysfunction, neurologic sequelae)

Ddx – Atypical HUS, HIT, ITP, DIC, tick borne illness, HELLP, macroaniopathy

Labs you should obtain: Dimer, fibrinogen, haptoglobin, LDH, PTINR, PTT, peripheral smear (schistocytes)

Management

Plasmapheresis (plasmic score to determine if empiric plasmapheresis is indicated while awaiting ADAMTS13 level [can take weeks])

High dose steroids

+/- rituximab (suppresses anti-ADAMTS13 production)

+/- caplacizumab – inhibits vWF interaction with platelets 

+/- aspirin if plt > 50k

***Hold platelet transfusion – increased risk for thrombosis

Plasmic Score (https://www.mdcalc.com/calc/10200/plasmic-score-ttp)

Validated w/ metaanalysis to risk stratify pts and determine need for empiric treatment. Yes = 1 point

Platelets < 30k

Evidence of hemolysis

Cancer (no = point)

Transplant (no = point)

MVC < 90

INR < 1.5

Cr < 2

6-7 points – high risk

5 – intermediate

0-4 – low risk

References:

https://www.ncbi.nlm.nih.gov/books/NBK430721/
https://www.emrap.org/corependium/chapter/rec3M4ex9nF4bKchk/Thrombotic-Thrombocytopenic-Purpura-TTP
https://www.uptodate.com/contents/diagnosis-of-immune-ttp
https://www.uptodate.com/contents/therapeutic-apheresis-plasma-exchange-or-cytapheresis-indications-and-technology?search=plasmapharesis&source=search_result&selectedTitle=1%7E150&usage_type=default&display_rank=1
Friday Board Review

Board Review by Dr. Edward Guo (Edited by Dr. Parikh)

A 60 year old male with a past medical history of colon adenocarcinoma presents for left leg swelling after a road trip. He denies fever, chest pain, or shortness of breath. Vital signs are within normal limits. On exam, the left lower extremity is neurovascularly intact with a palpable distal pulse. There is swelling and pitting edema of the left thigh and calf compared to the right. Compartments are soft and there is full range of motion without difficulty. Which of the following is the recommended treatment of his suspected condition?

A: Low molecular weight heparin (LWMH)

B: Rivaroxaban

C: Unfractionated heparin (UFH)

D: Warfarin

Answer: Low molecular weight heparin

This patient is likely experiencing a deep vein thrombosis of his lower extremity given his multiple risk factors and exam findings. Therapeutic anticoagulation should be initiated in the emergency department as the patient follows up outpatient. According to the American Society of Clinical Oncology guidelines, the recommended treatment of venous thromboembolism (VTE) in patients with cancer is LMWH. 

Rivaroxaban is a reasonable alternative but is associated with an increased risk of bleeding compared to LMWH. Subcutaneous UFH is not recommended for the outpatient treatment of acute VTE due to unpredictable bioavailability and effect requiring frequent monitoring. Warfarin causes an initial pro-thrombotic phase due to inhibition of protein C that would be potentially harmful in the case of active VTE which is why warfarin is typically co-administered with a secondary anticoagulant until the INR is in the desired therapeutic range for 2 consecutive days.

References:

Key NS, Khorana AA, Kuderer NM, et al. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol. 2020;38(5):496-520. doi:10.1200/JCO.19.01461

Kline JA. Venous Thromboembolism Including Pulmonary Embolism. In: Tintinalli JE, Ma O, Yealy DM, Meckler GD, Stapczynski J, Cline DM, Thomas SH. eds. Tintinalli’s Emergency Medicine: A Comprehensive Study Guide, 9e. McGraw-Hill Education; 2020.
Slattery DE, Pollack, Jr CV. Thrombotics and Antithrombotics. In: Tintinalli JE, Ma O, Yealy DM, Meckler GD, Stapczynski J, Cline DM, Thomas SH. eds. Tintinalli’s Emergency Medicine: A Comprehensive Study Guide, 9e. McGraw-Hill Education; 2020.

Treatment of Venous Thromboembolism in Patients with Cancer: Subgroup Analysis of the Matisse Clinical Trials, www.researchgate.net/publication/24261105_Treatment_of_venous_thromboembolism_in_patients_with_cancer_Subgroup_analysis_of_the_Matisse_clinical_trials. Accessed 19 Apr. 2024. 

Thursday Conference Content

Critically Appraised Topic: Is IM vs IN Naloxone less likely to require repeat dose in opioid overdose? By Dr. Roger Rothenberg

Study 1: A prospective, randomized, unblinded trial of patients in Victoria, Australia, with suspected opioid overdose with RR < 10 and who were unrousable. Exclusion criteria were patients who regained consciousness prior to treatment, those in whom incomplete data was recorded by EMS, and those with response associated with technical errors in recording or administration. Eligibility is not otherwise well-defined in this paper. Requirement for individual patient consent was waived. Subjects were informed of their participation by way of an information letter after regaining consciousness which allowed them to withdraw themselves from the study or seek further information. The objective of the study was to determine the efficacy of IN naloxone compared with IM naloxone for patients with acute respiratory depression secondary to suspected opiate overdose treated in the pre-hospital setting–determined by time to regain RR >  10/min. Secondary outcomes were pts with RR >  10 after 8 mins, proportion with GCS >  11 at 8 mins, proportion requiring rescue naloxone (given as 0.8mg IM dose), and rate of adverse events, defined as agitation, nausea/vomiting, headache, tremor, sweating. 155 subjects (after 27 excluded) were enrolled by paramedics to randomly receive either 2mg IN naloxone by means of a mucosal atomiser (1mg to each nostril) or 2 mg IM naloxone, in addition to BLS. Patients were followed until transport to hospital. Primary outcome of time to regain RR >  10 was 6 min in IM vs 8 min IN condition (P = 0.006). Additionally, a greater proportion of the IM group had regained RR >  10 at 8 mins (P = 0.0163). IN administration resulted in fewer incidents of agitation (P = 0.0278). Other secondary outcomes were not significantly different.

Study 2: Also a prospective, randomized, unblinded trial of patients in Melbourne, Victoria, Australia, with suspected opioid overdose (altered conscious state, pin-point pupils, respiratory rate < 10, unrousable as defined by GCS < 12 and had no major facial trauma, blocked nasal passages or epistaxis). As in the prior study, consent was waived and participation was able to be withdrawn after regaining consciousness. This study’s objective was to determine the effectiveness and safety of concentrated IN naloxone compared to IM naloxone for treatment of suspected opiate overdose in the pre-hospital setting. The primary outcome was the proportion of patients with RR >  9/min and/or GCS >  12 within 10 minutes of naloxone administration. Secondary outcomes included time to adequate response (as defined above), hospitalization, adverse event rate and requirement for ‘rescue’ naloxone (additional 0.8mg IM dose) due to inadequate primary response as judged by the treating paramedics. 172 patients were included in the study (after exclusion of 81 due to not meeting criteria, inadequate training, regaining alertness prior to intervention, and missing equipment) and enrolled by paramedics to receive 2mg IM naloxone or 2mg IN naloxone (concentrated in 1mL and administered 0.5mL per nostril), in addition to BLS. Patients were followed until transport to hospital. Primary outcomes were not significantly different between groups, nor were mean response times, however the number of patients requiring rescue dose naloxone was significantly greater in the IN group vs IM (P = 0.01), even after controlling for age, gender and suspected concomitant alcohol and/or drugs. Other secondary outcomes did not result in significant differences.

Conclusions: In these studies IM naloxone was less likely to result in need for repeat dosing with no significant difference in number of adverse events. In our practice, with patients receiving naloxone in the field and then brought to EMS triage, conditions for monitoring are not always ideal. In those patients in whom opioid overdose is suspected, IM naloxone is less likely to require repeat dosing. Based on my review of the literature, I would preferentially administer IM naloxone in patients with suspected opioid overdose.

Wednesday Image Review

What’s the Diagnosis? By Dr. Edward Guo

A 20 year old male presents to the emergency department via EMS for left knee pain. He was playing basketball when he jumped and felt a “pop” in his left knee and has been unable to walk on his left leg since. He denies falling. On exam, the left lower extremity is distally neurovascularly intact with normal strength, sensation, and a palpable pulse. There is slight bogginess and swelling with tenderness to palpation to the inferior knee. He is unable to extend at the knee. A point of care ultrasound of the bilateral knees is performed and shown below. What’s the diagnosis?

Answer: Left patellar tendon rupture

  • Commonly occurs from forced quadriceps contraction or falling on a flexed knee.
  • Associated with a high-riding patella also known as patella alta which can be appreciated on physical exam and lateral radiographs of the knee.
  • There is emerging data demonstrating point of care ultrasound as a quick and effective method to diagnose tendon injuries in the emergency department compared to physical exam, x-ray imaging, and MRI.
  • Treatment:
    • Incomplete tears with intact extensor mechanism can be immobilized and followed up outpatient with orthopedics.
    • Complete tears or loss of extensor mechanism should prompt orthopedic consultation in the ED as expedited surgical repair is often indicated.

References:

Bengtzen R. Knee Injuries. In: Tintinalli JE, Ma O, Yealy DM, Meckler GD, Stapczynski J, Cline DM, Thomas SH. eds. Tintinalli’s Emergency Medicine: A Comprehensive Study Guide, 9e. McGraw-Hill Education; 2020.

Berg, K., Peck, J., Boulger, C., & Bahner, D. P. (2013). Patellar tendon rupture: an ultrasound case report. BMJ case reports2013, bcr2012008189. https://doi.org/10.1136/bcr-2012-008189

Wu TS, Roque PJ, Green J, et al. Bedside ultrasound evaluation of tendon injuries. Am J Emerg Med. 2012;30(8):1617-1621. doi:10.1016/j.ajem.2011.11.004

Tuesday Advanced Cases

Alcohol Withdrawal By Dr. Sandhya Ashokkumar

HPI

  • A 53-year-old male with a history of chronic daily alcohol use presents to the ED via EMS after a witnessed seizure at home
  • The medics say he drinks every day, but his last drink was 3 days ago because he was not able to go to the store (history obtained from the sister who witnessed the seizure)

Physical Examination

T 98.3F, BP 177/106, HR 191, RR 22, Sat 93% 

  • Patient appears anxious, uncomfortable, and is actively vomiting blood tinged sputum
  • He appears confused and is not answering questions appropriately
  • He is tachycardic and his lungs are clear to auscultation bilaterally
  • Abd: soft NTND

Differential 

  • Alcohol withdrawal/ Delirium Tremens
  • Thyrotoxicosis
  • Sepsis
  • Pulmonary embolism
  • Heart failure

Workup and Management

  • The nurse informs you that the patient is seizing
  • This patient is exhibiting evidence of delirium tremens (psychomotor agitation and autonomic instability) and alcohol withdrawal seizure
  • The patient is no longer tolerating his secretions, he is confused, gurgling, and requires a definitive airway
  • After intubation, you bolus the patient with propofol and start him a propofol infusion
  • The patient is admitted to the ICU for further management

Teaching Points

  • ETOH withdrawal begins 6-8 hours after last intake and peaks in 72 hours 
  • Symptom based treatment via the CIWA score can help stratify patients, scores >15 indicate severe withdrawal
  • Start with IV diazepam at 10mg or lorazepam at 4mg and repeat them in doubling doses
  • Consider adding phenobarbital for refractory cases (i.e. after 200 mg of diazepam)
  • Consider propofol as the induction agent and sedative post-intubation as propofol potentiates GABA receptor activity and inhibits NMDA receptors Summary 
  • Delerium tremens can result in death from hyperthermia, arrhythmia and seizures

Sources:

Long D, Long B, Koyfman A. The emergency medicine management of severe alcohol withdrawal. The American Journal of Emergency Medicine. 2017;35(7):1005-1011. doi:10.1016/j.ajem.2017.02.002

Schuckit MA, Author Affiliations From the Department of Psychiatry. Recognition and Management of Withdrawal Delirium (Delirium Tremens): NEJM. New England Journal of Medicine. https://www.nejm.org/doi/10.1056/NEJMra1407298. Published February 5, 2015. Accessed December 9, 2020.